Ceramide inhibits antigen uptake and presentation by dendritic cells

J Exp Med. 1996 Dec 1;184(6):2411-6. doi: 10.1084/jem.184.6.2411.

Abstract

Ceramides are intramembrane diffusible mediators involved in transducing signals originated from a variety of cell surface receptors. Different adaptive and differentiative cellular responses, including apoptotic cell death, use ceramide-mediated pathways as an essential part of the program. Here, we show that human dendritic cells respond to CD40 ligand, as well as to tumor necrosis factor-alpha and IL-1 beta, with intracellular ceramide accumulation, as they are induced to differentiate. Dendritic cells down-modulate their capacity to take up soluble antigens in response to exogenously added or endogenously produced ceramides. This is followed by an impairment in presenting soluble antigens to specific T cell clones, while cell viability and the capacity to stimulate allogeneic responses or to present immunogenic peptides is fully preserved. Thus, ceramide-mediated pathways initiated by different cytokines can actively modulate professional antigen-presenting cell function and antigen-specific immune responses.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigen-Presenting Cells / immunology
  • Antigens / metabolism*
  • Biological Transport
  • CD40 Ligand
  • Cell Differentiation
  • Cell Survival
  • Cells, Cultured
  • Ceramides / biosynthesis*
  • Dendritic Cells / cytology
  • Dendritic Cells / drug effects
  • Dendritic Cells / physiology*
  • Endocytosis / drug effects
  • Humans
  • Interleukin-1 / pharmacology*
  • Kinetics
  • Membrane Glycoproteins / pharmacology
  • T-Lymphocytes / immunology
  • Tumor Necrosis Factor-alpha / pharmacology*

Substances

  • Antigens
  • Ceramides
  • Interleukin-1
  • Membrane Glycoproteins
  • Tumor Necrosis Factor-alpha
  • CD40 Ligand